<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Moderna Inc (NASDAQ: MRNA) shares are trading lower after Deutsche Bank initiated coverage on the stock with a Sell rating and a $250 price target. Moderna is also trading lower by 27% over the past month, potentially due to profit-taking after the stock ran higher by 108% from the July 7th session through the September 23rd session.
...read full article on Benzinga
